Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Lexicon Pharmaceuticals, Inc. (NQ: LXRX)
2.190 USD  UNCHANGED
Official Closing Price  /  Updated: 4:00 PM EDT, May 23, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Lexicon Pharmaceuticals, Inc.
 
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
PennyStocks101 Reports: 5 HOT STOCKS Trading on Friday: Lexicon Pharmaceuticals, Glu Mobile Inc., Biofuel Energy, Monster Beverage Corp., and Leap Wireless International
October 12, 2012
Beverly Hills, CA -- (SBWIRE) -- 10/12/2012 -- www.PennyStocks101.com provides its subscribers with timely information and exclusive charts on cheap and under-valued stocks in the United States with... Read More
from SBWire - Latest Press Releases
Stock to Watch: Lexicon Pharmaceuticals Up 7.1% (LXRX)
October 12, 2012
from Comtex SmarTrend® News Briefs
Pre-Open Movers 10/12: (LXRX) (IGTE) (STM) Higher; (AEZS) (AMD) (WFC) Lower (more...)
October 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7789398 for the full story. Read More
from StreetInsider.com News Articles
Lexicon (LXRX) Up as Phase 2 Trial Of Telotristat Etiprate Shows Positive Results
October 12, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7789357 for the full story. Read More
from StreetInsider.com News Articles
Friday’s biggest gaining and declining stocks
October 12, 2012
MarketWatch’s daily rundown of shares poised to make sizable moves in the U.S. stock market. Read More
category Earnings , INFY , Computer Software , and 17 more.
from MarketWatch
BRIEF-Lexicon Pharma shares up 12 percent in premarket
October 12, 2012
NEW YORK, Oct 12 (Reuters) - Lexicon Pharmaceuticals Inc : * Shares up 12 percent in premarket Read More
category companyNews
from Reuters: Company News
Lexicon Initiates Phase 3 Clinical Trial Of Telotristat Etiprate In Patients With Carcinoid Syndrome
October 12, 2012
from PR Newswire
Second Phase 2 Trial Of Telotristat Etiprate Shows Positive Results In Carcinoid Syndrome
October 12, 2012
Data Presented at North American Neuroendocrine Tumor Society Read More
from PR Newswire
Biotech Industry Looks to Benefit From New Legislation Passed to Help Speed Up FDA Review Process
September 13, 2012
The Paragon Report Provides Stock Research on Savient Pharmaceuticals and Lexicon Pharmaceuticals Read More
from Marketwired News Releases
Lexicon Pharmaceuticals To Present At The Morgan Stanley Global Healthcare Conference
September 07, 2012
from PR Newswire
Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
August 31, 2012
from PR Newswire
9 Biotechnology Stocks to Buy Now
August 19, 2012
 Read More
category NASDAQ:LXRX , NASDAQ:MDVN , NASDAQ:ISIS , and 7 more.
from InvestorPlace - Latest Headlines
Lexicon Pharmaceuticals, Inc. (LXRX) Results From Two Phase 1 Studies
August 16, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7666225 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
August 16, 2012
Top-Line Data from Phase 1 Studies of LX2931 and LX7101 Read More
from PR Newswire
Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
August 10, 2012
from PR Newswire
Needham & Company Reiterates a 'Buy' on Lexicon Pharmaceuticals (LXRX); Conference Call Takeaways
August 01, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7620784 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals (LXRX) Posts Narrower than Expected Q2 Loss of 5c/Sh.
July 31, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7615797 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
July 31, 2012
Conference Call at 11:00 a.m. Eastern Time Read More
from PR Newswire
Lexicon Pharma (LXRX) Files 13.24M Common Shelf for Selling Shareholders
July 26, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7608886 for the full story. Read More
from StreetInsider.com News Articles
Lexicon to Provide Second Quarter 2012 Financial Results
July 24, 2012
Conference Call and Webcast to Follow Read More
from PR Newswire
Needham & Company Maintains a 'Buy' on Lexicon Pharmaceuticals (LXRX); Big Pipeline Undervalued
July 18, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7588062 for the full story. Read More
from StreetInsider.com News Articles
Lexicon Pharmaceuticals and Rosetta Genomics Showing Impressive Growth in 2012
July 18, 2012
The Paragon Report Provides Stock Research on Lexicon Pharmaceuticals and Rosetta Genomics Read More
from Marketwired News Releases
Lexicon Pharmaceuticals Up 8.0%, Shares Break Through Resistance (LXRX)
July 16, 2012
from Comtex SmarTrend® News Briefs
Lexicon Pharmaceuticals: 52-Week High Recently Eclipsed (LXRX)
July 16, 2012
from Comtex SmarTrend® News Briefs
Hot Stock: Lexicon Pharmaceuticals, Shares Gain 6.3% (LXRX)
July 11, 2012
from Comtex SmarTrend® News Briefs
Streetinsider.com's Hot Lunchtime Reads 07/05: (FXI) (BUD) (JPM) (MSFT) (AAPL) (MCP)
July 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7562317 for the full story. Read More
from StreetInsider.com News Articles
Watch for Continued Gains in Shares of Lexicon Pharmaceuticals (LXRX)
July 05, 2012
from Comtex SmarTrend® News Briefs
Lexicon Pharma (LXRX) Shares Mark New 52-Week High as Technicians Buying
July 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7562182 for the full story. Read More
from StreetInsider.com News Articles
Hot Stock: Lexicon Pharmaceuticals, Shares Gain 6.4% (LXRX)
July 03, 2012
from Comtex SmarTrend® News Briefs
Booming Biotech Industry a Hotbed of Merger & Acquisition Activity and Speculation in 2012
July 03, 2012
Five Star Equities Provides Stock Research on Human Genome Sciences and Lexicon Pharmaceuticals Read More
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here